|
HSP's Revenue Growth by Quarter and Year
Hospira,'s Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| HSP Revenue (in millions $) |
FY 2014 |
FY 2013 |
FY 2012 |
FY 2011 |
| IV Quarter |
December |
-
|
1,084.40
|
1,098.90
|
1,014.00
|
| III Quarter |
September |
1,150.60
|
1,008.20
|
994.00
|
976.70
|
| II Quarter |
June |
1,135.80
|
1,026.20
|
1,033.30
|
1,064.10
|
| I Quarter |
March |
1,050.80
|
884.00
|
965.90
|
1,002.30
|
| FY |
|
3,337.20
|
4,002.80
|
4,092.10
|
4,057.10
|
| HSP Revenue third quarter 2014 Y/Y Growth Comment |
HOSPIRA, INC. achieved in the third quarter 2014, above Company average Revenue increase of 14.12% year on year, to $ 1,150.60 millions.
Looking into third quarter 2014 results within Major Pharmaceutical Preparations industry 61 other companies have achieved higher Revenue growth. While Hospira, Inc.' s Revenue growth of 14.12% ranks overall at the positon no. 1123 in the third quarter 2014.
|
| HSP Revenue ( Y/Y Growth %) |
2014
|
2013 |
2012 |
2011 |
| IV Quarter |
December |
- |
-1.32 % |
8.37 % |
2.21 % |
| III Quarter |
September |
14.12 % |
1.43 % |
1.77 % |
2.89 % |
| II Quarter |
June |
10.68 % |
-0.69 % |
-2.89 % |
9.9 % |
| I Quarter |
March |
18.87 % |
-8.48 % |
-3.63 % |
-0.53 % |
| FY |
|
- |
-2.18 % |
0.86 % |
3.57 % |
HSP Revenue (Quarter on Quarter Growth %) |
2014
|
2013 |
2012 |
2011 |
| IV Quarter |
December |
- |
7.56 % |
10.55 % |
3.82 % |
| III Quarter |
September |
1.3 % |
-1.75 % |
-3.8 % |
-8.21 % |
| II Quarter |
June |
8.09 % |
16.09 % |
6.98 % |
6.17 % |
| I Quarter |
March |
-3.1 % |
-19.56 % |
-4.74 % |
1.03 % |
| FY (Year on Year) |
|
- |
-2.18 % |
0.86 % |
3.57 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 33.91 % |
5.76 % |
-8.48 % |
| (Dec. 30. 2007) |
|
(March 31, 2013) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 33.91 % |
5.76 % |
-8.48 % |
| (Dec. 30. 2007) |
|
(March 31, 2013) |
|
| Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014 |
Hospira,'s Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 16.09 % |
1.43 % |
-19.56 % |
| (June 30, 2013) |
|
|
| HSP's III. Quarter Q/Q Revenue Comment |
HOSPIRA, INC. achieved in the III. Quarter 2014 below company average Revenue growth of 1.3% quarter on quarter, to $ 1,150.60 millions.
Albeit the III. Quarter 2014 Hospira,'s Revenue quarter on quarter growth was beneath the ordinary of 1.43 %, that was still good news, as the current surge, eclipses the -1.75% Revenue rise in the III. Quarter a year ago
Within Major Pharmaceutical Preparations industry 69 other companies have achieved higher Revenue quarter on quarter growth. While Hospira,'s Revenue growth quarter on quarter, overall rank is 2162. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 16.09 % |
1.43 % |
-19.56 % |
| (June 30, 2013) |
|
|
| HSP's III. Quarter Q/Q Revenue Comment |
HOSPIRA, INC. achieved in the III. Quarter 2014 below company average Revenue growth of 1.3% quarter on quarter, to $ 1,150.60 millions.
III. Quarter 2014 Revenue sequential growth appear to be a mixed bag, even if beneath the ordinary increase of 1.43 %, yet it demonstrates a quite improvement compare to the -1.75% in the III. Quarter a year ago.
Within Major Pharmaceutical Preparations industry 69 other companies have achieved higher Revenue quarter on quarter growth. While Hospira,'s Revenue growth quarter on quarter, overall rank is 2162. |
|
Hospira,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Sep. 30, 2014) |
12 Months Ending
(June 30. 2014) |
12 Months Ending
(March 31, 2014) |
12 Months Ending
(Dec 31 2013) |
12 Months Ending
(Sep. 30, 2013) |
| Cumulative Revenue 12 Months Ending |
$ 4,421.60 |
$ 4,279.20 |
$ 4,169.60 |
$ 6,921.20 |
$ 4,017.30 |
| Y / Y Revenue Growth (TTM) |
10.06 % |
6.9 % |
3.97 % |
69.14 % |
0.25 % |
| Year on Year Revenue Growth Overall
Ranking |
# 1301 |
# 1476 |
# 1472 |
# 1472 |
# 1472 |
| Seqeuential Revenue Change (TTM) |
3.33 % |
2.63 % |
4.17 % |
72.28 % |
0.35 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 1192 |
# 1362 |
# 0 |
# 0 |
# 1219 |
| Cumulative Revenue growth
Comment |
Hospira, saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.06% year on year, to $ 4,422 millions if the fiscal year would have ended in Sep. 30, 2014.
Hospira,'s trailing twelve months Revenue growth was higher than company's average 7.3% and higher than 6.9% growth in June 30. 2014.
But from twelve months ended June 30. 2014 growth rate was less at 3.33 % from $4279.2 millions achieved in twelve months ending a quarter before Brayden Schneider went on.
It appears to be slowdown in progress, more obvious observing the average Q/Q TTM historic advancement what is higher at 3.35%.
The momentum was even higher sequentially showed at 3.33 % increase from $4279.2 millions in twelve months ending a quarter before.
In the Healthcare sector 155 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1301, from total ranking in previous quarter at 1476. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
72.28 % |
3.35 % |
-2.02 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
69.14 % |
7.3 % |
-2.86 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 57 |
| Sector |
# 168 |
| S&P 500 |
# 1192 |
|
| Cumulative Revenue growth
Comment |
Hospira, saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.06% year on year, to $ 4,422 millions if the fiscal year would have ended in Sep. 30, 2014.
Hospira,'s trailing twelve months Revenue growth was higher than company's average 7.3% and higher than 6.9% growth in June 30. 2014.
But sequential growth rate was less at 3.33 % from $4279.2 millions achieved in twelve months ending a quarter June 30. 2014.
We witness drop-off in progress, more evident if you pay attention to the typical sequential Revenue rise what is better at3.35%.
The growth was much stronger from twelve months ended June 30. 2014 clinched at 3.33 % jump from $4279.2 millions in twelve months ending a quarter June 30. 2014.
In the Healthcare sector 155 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1301, from total ranking in previous quarter at 1476. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
72.28 % |
3.35 % |
-2.02 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
69.14 % |
7.3 % |
-2.86 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 57 |
| Sector |
# 168 |
| S&P 500 |
# 1192 |
|
24.22%